The present study is the first to seek evidence as to the possible direct relationship between chronic nitrate exposure via the consumption of contaminated water and alterations in thyroid function in rural areas of Durango.
As widely described in detail in the literature, human exposure to nitrates and nitrites occurs endogenously due to the metabolism of NO (Lundberg, Weitzberg & Gladwin 2008). It also occurs exogenously in the diet via different concentrations in drinking water and green leafy vegetables (Jonvik et al. 2016), food preservatives or flavorings in processed foods (Mortensen et al. 2017), and food supplements such as potassium nitrate and sodium nitrate (McDonagh et al. 2018). It is also present in medications that are mainly used to treat cardiovascular diseases (Lee & Gerriets 2019). The fact that the endogenous metabolism produces a much lower amount of nitrates and nitrites than that produced via the diet (Moretti et al. 2019) and the subjects’ null ingestion of food supplements should both be noted. In light of this, the main source of nitrate exposure in the study population is attributable to the consumption of water contaminated with these compounds.
While few studies have established base levels of nitrates in the organism, Mikiwa et al. (2002) found nitrate and nitrite levels of 36.6 ± 18.5 µmol/l and 6.4 ± 2.1 µmol/l, respectively, in the plasma of a sample of ten healthy subjects of Japanese origin. Pimková et al. (2014) found nitrite and nitrate levels of 1149 ± 86 nmol/l and 32.78 ± 10.33 µmol/l, respectively, in the plasma of a sample of 23 healthy subjects in the Czech Republic, while Lundberg & Weitzberg (2017) reported normal plasma levels of nitrates and nitrites ranging from 20–40 µmol/l and 50–300 nmol/l, respectively. In contrast, the present study obtained blood and urine nitrite levels of 23.95 ± 9 µmol/ml and 4.90 ± 4.90 µmol/ml, respectively, which may be related to the degree of exposure to nitrate via contaminated drinking water.
The physiological level of MetHb ranges from 0%-1% (Queirós et al. 2017) to 2% (Gómez et al. 2017). The lactating population is more prone to developing this condition as a result of the low level of methemoglobin reductase activity, while the ease with which fetal hemoglobin is oxidized and its more acidic gastric pH enable the intestinal microbiota to reduce the amount of nitrate ingested into nitrite. However, a notable correlation is not observed between the levels of nitrites in the blood and urine, while the high MetHb percentages observed is notable, wherein 79% of individuals analyzed presented levels over 1.5%, with an average of 2.80 ± 1.88.
Methemoglobinemia is a condition characterized by an abnormally high level (> 40%) of MetHb, which is mainly produced by acute exposure to oxidizing compounds, pharmaceuticals, and most chemical agents (Alanazi 2017). However, in the present study, the highest MetHb percentage, of 12.35%, was obtained from a study population which indicated, via the questionnaire, to having had no prior contact with any medication or chemical agent that could explain these high MetHb levels.
Another health aspect of interest to the present study is the state of thyroid function in the presence of chronic nitrate exposure. Nitrate, together with other sodium-iodide symporter inhibitors, is able to alter thyroid function (Horton et al. 2015), leading to it being suggested as a possible thyroid disruptor in humans (Bahadoran et al. 2015; Poulsen et al. 2018). In contrast to the findings obtained by Van Maanen et al. (1994), Tájtaková et al. (2006), Gatseva & Argirova (2008, 2008b), and Ward et al. (2010), our results do not provide data on abnormal growth, thyroid nodules, or the presence of any type of thyroid carcinoma. Moreover, while do not they concur with the reduced TSH levels and increased thyroid hormone levels found by the foregoing studies, they do show altered thyroid function after chronic nitrate exposure via potable water, ranging from 4.7 ± 3.3 mg/l to 56.9 ± 14.7 mg/l. Said alteration found in the present study corresponds to SCH and occurs due to the increased levels of TSH (up to 45%) and a reduction in T4T and T3T (up to 49% and 19.6%, respectively), a finding concurring with that reported by Aschebrook-Kilfoy et al. (2012). Another significant finding of the present study is the 85% urinary nitrite detected, which indicates that the study population exceeds the baseline (1 µmol/ml) and, thus, that high levels of these nitrogenated compounds are renally excreted in the presence of high nitrate concentrations in drinking water. Van Maanen et al. (1994) observed an increase in urinary nitrate which corresponded to the increased nitrate concentration in the drinking water of the study population, thus showing a dose-response relationship.
While previous studies have indicated the relationship between high levels of nitrates in potable water and altered thyroid function, others have shown that said relationship is not completely established and have not found structural or functional changes in the thyroid gland (Hunault et al. 2007). In contrast, the present study identified nitrate concentrations in potable water of up to 56.9 ± 14.7 mg/l, which is considered to be chronic exposure (≥ 1 year), further to identifying the presence of other conditioning factors for the development of SCH.
The prevalence of SCH found by the present study was 45%, which exceeds the national and global prevalence of 8% and 10%, respectively (Bruneel et al. 2016; Duntas 2019), and remains high even under the scenarios of low (40%), medium (45.6%), and high (48.4%) exposure. Hashimoto’s thyroiditis (a form of chronic lymphocytic thyroiditis or chronic autoimmune thyroiditis) is characterized by the autoimmune destruction of the thyroid gland, which leads to epithelial cell apoptosis and diffuse lymphocytic infiltration due to the action of specific B and T cells. Moreover, it also causes follicular destruction (Liontiris & Mazokopakis 2017) that leads to reduced levels of thyroid hormone synthesis. This chronic autoimmune thyroiditis is the main cause of both clinical and subclinical primary hypothyroidisms in areas with sufficient or excessive iodine content (Duntas 2019; Zimmermann & Boelaert 2015). This is accompanied by the presence of anti-thyroid antibodies, mainly TPO and anti-thyroglobulin antibodies, which are considered biomarkers of thyroid gland damage (Radetti 2014). In contrast with the 60% established by Bromińska et al. (2017) and Malathi et al. (2013) and the 50% established by Jayashankar et al. (2015), the present study found an SCH level of 15.7% in the presence of TPO-Ab (> 35 UI/ml). Therefore, autoimmune disorders would not be the main cause of SCH in the families of the study population. Although the exact etiology of the development of Hashimoto’s thyroiditis remains to be established, the interaction among genetic susceptibility factors, nutritional factors, and environmental triggers may be involved (Hu & Rayman 2017).
Alterations in the synthesis and secretion of thyroid hormones may be a consequence of a perturbation in the expression of the genes encoding thyroid transcription factors or the presence of genetic variations therein (Fernández et al. 2015). The gene FOXE1 plays an important role in the growth and development of the thyroid glands and the proliferation and differentiation of follicular thyroid cells and acts as a regulator of cell function, growth, and differentiation (Chen & Zhang 2018). Two of its polymorphisms, rs965513[A] and rs1867277[A], contribute independently to establishing a predisposition for the development of papillary thyroid cancer (Nikitski et al. 2017). Similarly, the presence of the allele of rs965513 polymorphism impacts on thyroid function, reducing the levels of TSH and T4F, increases T3F levels (Gudmundsson et al. 2009), and is associated with the development of hypothyroidism and goiter (Denny et al. 2011). Furthermore, the presence of the allele of rs965513 polymorphism participates in the recruitment of the USF1/2 factors by the FOXE1 promoter, resulting in an alteration in the state of FOXE1 gene expression (Landa et al. 2009). Furthermore, it has been found that genetic variations in FOXE1, including rs965513 and rs1867277, are risk factors associated with increased susceptibility to differentiated thyroid cancer (Chen & Zhang 2018; Geng et al. 2015). In terms of the results of the present study, the frequency of the occurrence of the polymorphic allele in the study population was 30% for rs965513 [A] and 37% for rs1867277 [A], which is in line with global (rs965513 [A] = 20% and rs1867277 [A] = 31%) and national (rs965513 [A] = 26% and rs1867277 [A] = 29%) levels. Considering that only the AA genotype of both polymorphisms could be the cause of thyroid function alterations, the present study found the presence of the genetic variants rs965513 and rs2200733 in only 3 and 4%, respectively, of the SCH cases found, thus reducing the impact of genetic factors in the study population.
Increased body weight is one correlation plausibly connected to the presence of SCH, in that hypothyroidism and SCH provide the conditions for reduced metabolic function, alterations in thermogenesis, and processes involving the metabolism of both glucose and lipids. This translates into weight gain over the long-term, once the level of thyroid hormone synthesis begins to decrease (Sanyal & Raychaudhuri 2016). Given the foregoing, it is possible that the correlation between age and BMI found in the present study may reveal that the older a subject, the greater their exposure to nitrates and, consequently, the greater the alteration in metabolic processes, thus resulting in weight gain. However, we also consider that said correlation would be affected by other factors such as nutritional variation, sedentarism, and, even, the inherent relationship with growth, without underplaying the importance of said correlation in itself.
It should be noted that some studies indicate a relationship between increased BMI and increased thyroid hormone (T3F) levels (Taylor et al. 2016; Xu et al. 2019), while others maintain that changes in serum thyroid hormone (F4T) may cause increases in BMI (Abdi et al. 2017). The foregoing is the opposite of the negative correlation found in the present study between BMI and T3L levels (r = 0.031, r2 = 0.096, p = 0.001), for which reason, we consider that high nitrate exposure would play an important role in the thyroid profile and merits attention in the study population.
In terms of the relationship observed between age and thyroid profile, the results of the present study provide evidence of a negative and statistically significant correlation. However, the production of hormones regulated by the endocrine system, including the thyroid hormones, decreases due to aging, which causes general morphological and physiological changes (Barbesino 2019). Nevertheless, the importance of the chronic presence of nitrate as an inhibitor of iodine uptake in the thyroid gland cannot be understated.
It is of the utmost importance to highlight that the following environmental characteristics of the rural region in which the present study was carried out are a problem with real impacts on human health: intermittent rainfall; soil/aquifer contamination via inorganic nitrate and other compounds; over-fertilization; over-use of land for forage crops; and, intensive livestock and agricultural practices. Not only are said problems present in rural zones of Durango, Mexico, but are also, today, without a doubt, a public health and environmental problem in large parts of the world (Shukla & Saxena, 2019).
As discussed above, the development of SCH may have a multifactorial origin (Ibañez, 2017). However, Table 4 clearly shows that SCH presents in each of the exposure scenarios, thus suggesting that, further to the high nitrate levels, it is chronic nitrate exposure that provides the conditions for alterations in thyroid function.